Influence of stable, long-term treatment with phenobarbital on the activity of serum alanine aminotransferase and γ-glutamyltransferase

British Journal of Biomedical Science

Volumn 65, Issue 3, 2008, Pages 132-135

  Lippi, Giuseppe ^a   Montagnana, M ^a   Salvagno, G L ^a   Guidi, G C ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Alanine aminotransferase; Enzymes; Gamma Glutamyltransferase; Liver; Phenobarbital

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; PHENOBARBITAL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; FOCAL EPILEPSY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAND MAL EPILEPSY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TEMPORAL LOBE EPILEPSY;

EID: 53849090636     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2008.11732816     Document Type: Article

References (14)

1. Kwan P, Brodie MJ. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004; 45: 1141-9.
2. Gastaut H, Osontokun BO. Proposals on antiepileptic pharmacotherapy for use in developing countries. Epilepsia 1976; 17: 355-60.
3. Walia KS, Khan EA, Ko DH, Raza SS, Khan YN. Side effects of antiepileptics - a review. Pain Pract 2004; 4: 194-203.
4. Iivanainen M, Savolainen H. Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy. Acta Neurol Scand Suppl 1983; 97: 49-67.
5. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999; 23: 40-54.
6. Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998; 351: 19-23.
7. Gaskill CL, Miller LM, Mattoon JS et al. Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital. Vet Pathol 2005; 42: 147-60.
8. Kawasaki H, Murawaki Y, Kimura N, Hrayama C. Effects of phenobarbital on unconjugated bilirubin clearance, gamma-glutamyltranspeptidase and urinary D-glucaric acid in patients with Gilbert's syndrome. Hepatogastroenterology 1982; 29: 252-5.
9. Hirayanagi N, Fujii E, Teshirogi T. The significance of serum gamma-glutamyl transpeptidase (gamma-GTP) elevation caused by antiepileptic drug(s). Using the antipyrine metabolic capacity as a parameter of microsomal enzyme activity (in Japanese). Nippon Ika Daigaku Zasshi 1991; 58: 547-60.
10. Tutor-Crespo MJ, Hermida-Ameijeiras J, Tutor-Valcarce JC. A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs (in Spanish). Rev Neurol 2002; 35: 711-6.
11. Sirica AE, Jicinsky JK, Heyer EK. Effect of chronic phenobarbital administration on the gamma-glutamyl transpeptidase activity of hyperplastic liver lesions induced in rats by the Solt/Farber initiation: selection process of hepatocarcinogenesis. Carcinogenesis 1984; 5: 1737-40.
12. Foster SF, Church DB, Watson AD. Effects of phenobarbitone on serum biochemical tests in dogs. Aust Vet J 2000; 78: 23-6.
13. Gieger TL, Hosgood G, Taboada J, Wolfsheimer KJ, Mueller PB. Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration. J Vet Intern Med 2000; 14: 277-81.
14. Huseby NE. Suboellular localization of gamma-glutamyltransferase activity in guinea pig liver. Effect of phenobarbital on the enzyme activity levels. Clin Chim Acta 1979; 94: 163-71.